“The cholera bacterium has undergone important mutations in recent years, causing longer outbreaks of the disease with increased fatalities, researchers reported on Wednesday,” Reuters reports. “In a package of papers published in the journal PLoS Neglected Tropical Diseases, they said mass vaccinations should be considered as a solution even after outbreaks have begun,” the news service writes (Lyn, 1/26).
“A joint venture between U.S. drugmaker Merck and Britain’s Wellcome Trust charity said on Monday it is working on an oral rotavirus vaccine designed to be cheaper and easier to use than current shots,” Reuters reports. “Hilleman Laboratories, an India-based joint venture set up on a not-for-profit basis in 2009, said the vaccine will aim to protect against diarrhea-causing rotavirus infections and will be based on thin strips or granules that dissolve in the mouth and can be easily transported, stored and administered.”
Al Jazeera examines the toll pneumonia and diarrhea take on children living in developing countries and how the GAVI Alliance is working to help improve health outcomes among children through the distribution of pneumonia vaccines around the world.
Dominican Republic Reports Country’s First Cholera Death Following Outbreak In Haiti “Dominican Republic on Sunday confirmed that a 53-year-old Haitian man has become the country’s first death from cholera and announced the immediate start of a broad disease control and monitoring operation” around the eastern town of Higuey where he…
Individuals traveling across East Africa on Friday were ordered to begin receiving mandatory yellow fever vaccines in an effort “to contain an outbreak of the disease in Uganda,” which has sickened an estimated 190 people, resulting in 48 deaths as of Dec. 30, 2010, the Citizen reports (Ubwani, 1/22).
As the WHO executive board continues meeting in Geneva this week, members “on Thursday backed efforts by the U.S. and Russia to keep the last known stocks of the smallpox virus for research to combat terrorism, in an initial debate over the fate over what is left of one of the world’s most lethal pathogens,” the Wall Street Journal reports. According to the article, the 34-member board supported the notion “that those stocks are needed to finish developing drugs and vaccines to counter a potential bioterror attack or accidental release of smallpox from unsanctioned stocks, officials familiar with the talks said.”
Developing and developed countries that require children to be vaccinated against rotavirus “have significantly reduced the number of children admitted to hospitals with the disease, a report showed on Thursday,” Reuters reports (Kelland, 1/20).
Insecticides To Fight Malaria: In a Daily Caller opinion piece, Richard Tren of Africa Fighting Malaria andÂ Donald Roberts of the Uniformed Services University of the Health Sciences write in support of using insecticides, like DDT, to combat malaria: “Unless the donor nations that fund global malaria programs, such as the…
Intellectual Property Watch reports on how delegates at WHO’s executive board meeting used Wednesday to discuss WHO policy on counterfeit and substandard medications. According to the news service, WHO “members â€¦ raised strong concerns that a working group they mandated last May to address problems with WHO policy on counterfeit and substandard medicines has yet to be formed â€“ with four months remaining before it must report back to members.”
Sufficient Support Of GAVI Would Go Long Way ToÂ Preventing Premature Deaths Around The WorldÂ “Vaccines are among the greatest scientific contributions to human welfare. They are also some of the largest humanitarian contributions of developed nations to the rest of the world. So it is unfortunate that a decade of…